Form: 3

Initial statement of beneficial ownership of securities

September 12, 2018

FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Pettigrew Donald B
 2. Date of Event Requiring Statement (Month/Day/Year)
09/04/2018		 3. Issuer Name and Ticker or Trading Symbol
REPRO MED SYSTEMS INC [REPR]
(Last)
(First)
(Middle)
REPRO MED SYSTEMS, INC., 24 CARPENTER ROAD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Pres./Chief Commercial Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

CHESTER, NY 10918		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 0
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to Purchase Common Stock   (1) 09/04/2023 Common Stock 1,000,000 $ 1.23 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Pettigrew Donald B
REPRO MED SYSTEMS, INC.
24 CARPENTER ROAD
CHESTER, NY 10918		       Pres./Chief Commercial Officer  

Signatures

/s/ Donald B. Pettigrew 09/12/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) REPRO MED SYSTEMS, INC. d/b/a RMS Medical Products (the "Company") hired Mr. Pettigrew on September 4, 2018 and as part of his employment agreement he was awarded these non-qualified stock options on the same date under the Company's 2015 Stock Option Plan, as amended. Twenty-five percent (25%) of the options shall vest as of the one (1) year anniversary of September 4, 2018, and (ii) twelve and one-half percent (12.5%) of the options shall vest every six (6) months thereafter until fully vested, subject to acceleration in accordance with the terms of the award agreement.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.